Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that involves a pathological inflammatory response against articular cartilage in multiple joints throughout the body. It is a complex disorder associated with comorbidities such as depression, lymphoma, osteoporosis, and cardiovascular disease (CVD), which significantly deteriorate patients’ quality of life and prognosis. This has ignited a large initiative to elucidate the physiopathology of RA, aiming to identify new therapeutic targets and approaches in its multidisciplinary management. Recently, various lipid bioactive products have been proposed to have an essential role in this process, including eicosanoids, specialized pro-resolving mediators, phospholipids/sphingolipids, and endocannabinoids. Dietary interventions using omega-3 polyunsaturated fatty acids or treatment with synthetic endocannabinoid agonists have been shown to significantly ameliorate RA symptoms. Indeed, the modulation of lipid metabolism may be crucial in the pathophysiology and treatment of autoimmune diseases.
Keywords: Rheumatoid arthritis, inflammation, bioactive lipids, resolving, autoimmune disease, cardiovascular disease.
Related Journals
Current Topics in Medicinal Chemistry
Recent Advances in Inflammation & Allergy Drug Discovery
Coronaviruses
Current Probiotics
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Anti-Infective Agents
Current Pharmaceutical Analysis
Related Books
Antibodies Applications and New Developments
Frontiers in Inflammation
Frontiers in Inflammation
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research – Anti Allergy Agents
Immunology of Pregnancy 2013
Meta-Inflammation and Obesity
34